MassIVE MSV000096839

Partial Public PXD059731

Structural obstruction to full DNA replication in the chromatin of terminally differentiated skeletal muscle cells

Description

Terminal cell differentiation is often associated with permanent withdrawal from proliferation, termed the postmitotic state. Though widespread among vertebrates and determinant for their biology, the molecular underpinnings of this state are poorly understood. Postmitotic skeletal muscle myotubes can be induced to reenter the cell cycle; however, they generally die as a result of their inability to complete DNA replication. Here, we explore the causes of such incompetence. Genomic hybridization of newly synthesized DNA showed that the replicative failure does not concern specific genomic regions, but can stochastically affect any of them. Myoblast and myotube were incubated in replicative Xenopus egg extract, which provides a full DNA replication machinery. While myoblast nuclei attained complete DNA replication, those from myotubes, even in these conditions, duplicated less than half of their genomes, strongly indicating that the very structure of myotube chromatin obstructs DNA replication. Furthermore, disassembling and disorganizing chromatin with a strong salt treatment did not modify the replicative differences between the two nucleus types, suggesting that they are rooted in the core structure of chromatin. Proteomic methods Cells were harvested, centrifuged, then washed once in PBS. To isolate nuclei, pellets were resuspended in Hypotonic Buffer (10mM HEPES pH 7.5, 2 mM KCl, 2 mM MgCl2, 3 mM EDTA, HALT Protease Inhibitors, 1 mM 1,4 DTT) and incubated on ice for 30 or 60 min. Myoblasts were then centrifuged again and resuspended in PBS containing 25 ug/ml trypsin, then incubated for 2 min to release nuclei. Myotubes received a similar treatment, but were resuspended in 37.5 ug/ml trypsin and incubated for 4 minutes. To stop digestion, PMSF was added to a final concentration of 1 mM and the solution was incubated for 5 min on ice. To permeabilize the nuclear membrane, a final concentration of 0.2 percent Triton X-100 was added to the suspension. After 5 min of incubation on ice, isolated nuclei were centrifuged as above and resuspended in Iso Buffer (10 mM HEPES pH 7.5, 25 mM KCl, 2 mM MgCl2, 75 mM sucrose, 0.5 mM PMSF, 1 mM DTT)). For mass spectrometry analyses, freshly isolated nuclei were washed once in Iso Buffer, suspended in 50 mM ammonium bicarbonate, and sonicated. Proteins extracted from nuclei treated or not with 0.5 M NaCl were analyzed by LC-MSMS after cysteine reduction with 1 mM TCEP and alkylation with 12 mM iodoacetamide, and overnight digestion with trypsin (protein ratio 1:50 w:w) at 37 degree. Peptides were then injected into an Ultimate 3000 UHPLC (Dionex, Thermo Fisher Scientific) in line with an Orbitrap Fusion Tribrid mass spectrometer (Thermo Fisher Scientific). After a desalting step in a trap column, analytical separations were performed on a single 45 cm long silica capillary packed in house with a C18, and heated at 45 degree in an oven (Sonation). A 90 min long HPLC gradient was used. The Data Independent Acquisition (DIA) mode was used. MS data were acquired in the 300-1200 m over z range split into 40 contiguous windows with 1 m over z overlap, fragmented by HCD 28 percent, and the MS2 spectra were acquired in the Orbitrap at 30K resolution in the 145 to 1450 m over z range. Protein identification was obtained using the SwissProt mouse database containing the manually curated list of histones (24,945 sequences) obtained from El Kennani. The raw data were analyzed with the DIA-NN software v. 1.8.1. Statistical analyses were performed using the Perseus software (v. 2.0.11). Data analyses regarded only nuclear proteins, based on SwissProt annotations, while contaminating non nuclear proteins were ignored. To evaluate significant changes in protein abundances between NaCl treated and untreated samples, raw intensity values were normalized to total core histone values. After normalization, all values were transformed to log2. Only proteins quantified in at least 5 of 8 samples were considered. Missing values were imputed, replacing them with values from the normal distribution (Width 0.3, Down Shift 1.8). Significance was evaluated using Students t-Test (FDR 0.05, S0 = 0.1, 250 randomization). [doi:10.25345/C5KH0FB2S] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: cell cycle nuclei muscle skeletal cell ; DatasetType:Proteomics

Contact

Principal Investigators:
(in alphabetical order)
Serena Camerini, istituto superiore di sanita, Italia
Submitting User: serena_camerini

Publications

Zribi S, Giannitelli GJ, Bernardini L, Censi F, Camerini S, Bertuccini L, Iosi F, Giannella E, Sanchez M, Consoli E, Casagrande A, Cenci A, Floridia G, Novelli A, Giuliani A, Costanzo V, Crescenzi M, Pajalunga D.
Structural obstruction to full DNA replication in terminally differentiated skeletal muscle cells.
Zribi S, Giannitelli GJ, Bernardini L, Censi F, Camerini S, Bertuccini L, Iosi F, Giannella E, Sanchez M, Consoli E, Casagrande A, Cenci A, Floridia G, Novelli A, Giuliani A, Costanzo V, Crescenzi M, Pajalunga D. Structural obstruction to full DNA replication in terminally differentiated skeletal muscle cells. EMBO Rep. 2025 Aug 26. doi: 10.1038/s44319-025-00554-x. Epub ahead of print. PMID: 40859015.

Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

- Dataset Reanalyses


+ Dataset History


Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.